These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22215041)

  • 1. Fibronectin molecular status determination useful to differentiate between rheumatoid arthritis and systemic lupus erythematosus patients.
    Przybysz M; Borysewicz K; Kątnik-Prastowska I
    Rheumatol Int; 2013 Jan; 33(1):37-43. PubMed ID: 22215041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
    Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
    Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma fibronectin in patients with systemic lupus erythematosus.
    Nishinarita S; Yamamoto M; Takizawa T; Hayakawa J; Karasaki M; Sawada S
    Clin Rheumatol; 1990 Jun; 9(2):214-9. PubMed ID: 2202543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Ed-B fibronectin plasma levels in spondyloarthropathies: comparison with rheumatoid arthritis patients and a healthy population.
    Claudepierre P; Allanore Y; Belec L; Larget-Piet B; Zardi L; Chevalier X
    Rheumatology (Oxford); 1999 Nov; 38(11):1099-103. PubMed ID: 10556262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope specificity of antibodies to type II collagen in rheumatoid arthritis and systemic lupus erythematosus.
    Rowley MJ; Mackay IR; Brand CA; Bateman JF; Chan D
    Rheumatol Int; 1992; 12(2):65-9. PubMed ID: 1384102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis.
    Wallace DJ; Gavin IM; Karpenko O; Barkhordar F; Gillis BS
    Rheumatol Int; 2015 Jun; 35(6):991-6. PubMed ID: 25377646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of circulating cellular fibronectin are increased in patients with rheumatoid vasculitis.
    Voskuyl AE; Emeis JJ; Hazes JM; van Hogezand RA; Biemond I; Breedveld FC
    Clin Exp Rheumatol; 1998; 16(4):429-34. PubMed ID: 9706423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synovial fibronectin fragmentation and domain expressions in relation to rheumatoid arthritis progression.
    Przybysz M; Borysewicz K; Szechinski J; Katnik-Prastowska I
    Rheumatology (Oxford); 2007 Jul; 46(7):1071-5. PubMed ID: 17459959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of EDA(+) fibronectin and its clinical importance on cryofiltration.
    Kawamura A; Yonekawa M; Takahashi M; Meguro J; Yanagida N; Kurauchi N; Ikeda A; Kukita K; Sakashita E
    Int J Artif Organs; 1994 Oct; 17(10):559-64. PubMed ID: 7896431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
    Zhao M; Zhou Y; Zhu B; Wan M; Jiang T; Tan Q; Liu Y; Jiang J; Luo S; Tan Y; Wu H; Renauer P; Del Mar Ayala Gutiérrez M; Castillo Palma MJ; Ortega Castro R; Fernández-Roldán C; Raya E; Faria R; Carvalho C; Alarcón-Riquelme ME; Xiang Z; Chen J; Li F; Ling G; Zhao H; Liao X; Lin Y; Sawalha AH; Lu Q
    Ann Rheum Dis; 2016 Nov; 75(11):1998-2006. PubMed ID: 26787370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
    Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
    Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
    Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
    Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Capacity of High-Density Lipoprotein Cholesterol Efflux Between Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Quevedo-Abeledo JC; Sánchez-Pérez H; Tejera-Segura B; de Armas-Rillo L; Armas-González E; Machado JD; González-Gay MA; Díaz-González F; Ferraz-Amaro I
    Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1590-1596. PubMed ID: 32770725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?
    Zhao Y; Li J; Li XX; Li C; Li L; Li ZG
    Joint Bone Spine; 2009 Oct; 76(5):501-7. PubMed ID: 19289297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of anti-citrullinated peptide and anti-RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis.
    Mediwake R; Isenberg DA; Schellekens GA; van Venrooij WJ
    Ann Rheum Dis; 2001 Jan; 60(1):67-8. PubMed ID: 11114286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a Novel Serum Proteomic Signature for Primary Sjögren's Syndrome.
    Padern G; Duflos C; Ferreira R; Assou S; Guilpain P; Maria ATJ; Goulabchand R; Galea P; Jurtela M; Jorgensen C; Pers YM
    Front Immunol; 2021; 12():631539. PubMed ID: 33708222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.
    Popescu C; Zofotă S; Bojincă V; Ionescu R
    Rom J Intern Med; 2013; 51(3-4):179-87. PubMed ID: 24620631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis.
    dos Anjos LM; Pereira IA; d 'Orsi E; Seaman AP; Burlingame RW; Morato EF
    Clin Rheumatol; 2009 Feb; 28(2):153-8. PubMed ID: 18795390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophoretic characterization of species of fibronectin bearing sequences from the N-terminal heparin-binding domain in synovial fluid samples from patients with osteoarthritis and rheumatoid arthritis.
    Peters JH; Carsons S; Yoshida M; Ko F; McDougall S; Loredo GA; Hahn TJ
    Arthritis Res Ther; 2003; 5(6):R329-39. PubMed ID: 14680507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.